Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. N-(8-(2-hydroxybenzoyl)amino)caprylate
2. N-(8-(2-hydroxybenzoyl)amino)caprylate Sodium
3. N-snac
4. Snac Sodium
5. Sodium N-(8-(2-hydroxybenzoyl)amino)caprylate
1. 203787-91-1
2. Snac
3. Sodium 8-(2-hydroxybenzamido)octanoate
4. E414
5. Salcaprozate Sodium [usan]
6. Sodium;8-[(2-hydroxybenzoyl)amino]octanoate
7. Octanoic Acid, 8-[(2-hydroxybenzoyl)amino]-, Monosodium Salt
8. Salcaprozate (sodium)
9. Sodium,8-[(2-hydroxybenzoyl)amino]octanoate
10. 1ytw0422yu
11. Sodium 8-[(2-hydroxybenzoyl)amino]octanoate
12. E-414
13. Sodium 8-((2-hydroxybenzoyl)amino)octanoate
14. Salcaprozate Sodium (usan)
15. Octanoic Acid, 8-((2-hydroxybenzoyl)amino)-, Monosodium Salt
16. Sodium Salcaprozate
17. Unii-1ytw0422yu
18. Salcaprozic Acid, Sodium Salt
19. E 414
20. Salcaprozate Sodium, 99%
21. Salcaprozic Acid Sodium Salt
22. Schembl825599
23. Chembl2107027
24. Dtxsid50174306
25. Amy24031
26. Ex-a3434
27. Mfcd00952954
28. Sodium8-(2-hydroxybenzamido)octanoate
29. Ac-31357
30. As-65676
31. P414
32. Hy-114299
33. Cs-0081977
34. Ft-0696582
35. D05787
36. I10998
37. A879665
38. Q27253228
39. Sodium 8-[(2-hydroxyphenyl)formamido]octanoate
40. Octanoic Acid, 8-[(2-hydroxybenzoyl)amino]-, Sodium Salt
41. Sodium,8-[(2-hydroxybenzoyl)amino]octanoate;sodium 8-(2-hydroxybenzamido)octanoate
Molecular Weight | 301.31 g/mol |
---|---|
Molecular Formula | C15H20NNaO4 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 9 |
Exact Mass | 301.12900240 g/mol |
Monoisotopic Mass | 301.12900240 g/mol |
Topological Polar Surface Area | 89.5 Ų |
Heavy Atom Count | 21 |
Formal Charge | 0 |
Complexity | 312 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 40707
Submission : 2024-11-26
Status : Active
Type : IV
Zhejiang Hengkang Pharm Group is a dynamic pharmaceutical entity, spanning drug research, large-scale production, and global marketing.
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 40217
Submission : 2024-07-22
Status : Active
Type : IV
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Omgene: R&D-based biopharmaceutical company with GMP facilities, focused on innovation and high-quality, affordable medicines.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 40767
Submission : 2024-11-11
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 39618
Submission : 2024-10-10
Status : Active
Type : IV
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Market Place
ABOUT THIS PAGE
54
PharmaCompass offers a list of Salcaprozate Sodium API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Salcaprozate Sodium manufacturer or Salcaprozate Sodium supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Salcaprozate Sodium manufacturer or Salcaprozate Sodium supplier.
PharmaCompass also assists you with knowing the Salcaprozate Sodium API Price utilized in the formulation of products. Salcaprozate Sodium API Price is not always fixed or binding as the Salcaprozate Sodium Price is obtained through a variety of data sources. The Salcaprozate Sodium Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Salcaprozate (sodium) manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Salcaprozate (sodium), including repackagers and relabelers. The FDA regulates Salcaprozate (sodium) manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Salcaprozate (sodium) API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Salcaprozate (sodium) manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Salcaprozate (sodium) supplier is an individual or a company that provides Salcaprozate (sodium) active pharmaceutical ingredient (API) or Salcaprozate (sodium) finished formulations upon request. The Salcaprozate (sodium) suppliers may include Salcaprozate (sodium) API manufacturers, exporters, distributors and traders.
click here to find a list of Salcaprozate (sodium) suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Salcaprozate (sodium) DMF (Drug Master File) is a document detailing the whole manufacturing process of Salcaprozate (sodium) active pharmaceutical ingredient (API) in detail. Different forms of Salcaprozate (sodium) DMFs exist exist since differing nations have different regulations, such as Salcaprozate (sodium) USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Salcaprozate (sodium) DMF submitted to regulatory agencies in the US is known as a USDMF. Salcaprozate (sodium) USDMF includes data on Salcaprozate (sodium)'s chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Salcaprozate (sodium) USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Salcaprozate (sodium) suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Salcaprozate (sodium) as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Salcaprozate (sodium) API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Salcaprozate (sodium) as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Salcaprozate (sodium) and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Salcaprozate (sodium) NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Salcaprozate (sodium) suppliers with NDC on PharmaCompass.
Salcaprozate (sodium) Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Salcaprozate (sodium) GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Salcaprozate (sodium) GMP manufacturer or Salcaprozate (sodium) GMP API supplier for your needs.
A Salcaprozate (sodium) CoA (Certificate of Analysis) is a formal document that attests to Salcaprozate (sodium)'s compliance with Salcaprozate (sodium) specifications and serves as a tool for batch-level quality control.
Salcaprozate (sodium) CoA mostly includes findings from lab analyses of a specific batch. For each Salcaprozate (sodium) CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Salcaprozate (sodium) may be tested according to a variety of international standards, such as European Pharmacopoeia (Salcaprozate (sodium) EP), Salcaprozate (sodium) JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Salcaprozate (sodium) USP).